- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 14:30 | Duos expands edge data center footprint to Illinois and Texas markets | ||
| 14:30 | Beyond Oil receives additional order from Hungarian distributor | ||
| 14:30 | Silo Pharma signs LOI with Allucent for SPC-15 nasal spray clinical trials | ||
| 14:30 | Safe Harbor adds two key executives to leadership team | ||
| 14:30 | Spectral Capital to acquire Telvantis Voice Services in stock deal | ||
| 14:30 | ITC launches investigation into Samsung over Netlist patent claims | ||
| 14:30 | Kratos completes testing of satellite control software with Airbus OneSat | ||
| 14:30 | GomSpace lands 50MSEK defense contract for microsatellite platform | ||
| 14:30 | Westminster Group AGM: three resolutions pass, four withdrawn | ||
| 14:30 | Meta stock price target reiterated at $1,117 by Rosenblatt on Manus acquisition | ||
| 14:06 | iShares Digital Assets AG issues new tranche of bitcoin ETP | ||
| 14:06 | IM Cannabis explores US entry following Trump's marijuana order | ||
| 14:06 | Mogo rebrands as Orion Digital, shifts focus to multi-engine platform | ||
| 14:06 | Gowin New Energy Group appoints Chien as CEO as Chen resigns | ||
| 13:54 | Takeda regains majority of mezagitamab royalty interest from XOMA | ||
| 13:54 | ZenaTech completes three drone service acquisitions across North America | ||
| 13:54 | DeFi Technologies outlines growth strategy in year-end letter | ||
| 13:54 | InflaRx reports potential efficacy signals in failed PG drug trial | ||
| 13:54 | Beyond Air appoints Dan Moorhead as new CFO effective January 2026 | ||
| 13:54 | Profusa restructures convertible note to reduce dilution, increase flexibility | ||
| 13:54 | Wedbush initiates coverage on RPT Realty stock with Outperform rating | ||
| 13:42 | Praxis Precision Medicines stock gets FDA boost as H.C. Wainwright maintains Buy | ||
| 13:42 | reAlpha Tech stock maintains Buy rating at H.C. Wainwright following InstaMortgage acquisition | ||
| 13:42 | Zevra Therapeutics stock maintains Buy rating at H.C. Wainwright on expanded access deal | ||
| 13:42 | H.C. Wainwright reiterates Buy rating on Vir Biotechnology stock |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .